Boston Scientific is "significantly reducing" the salaries of its CEO, board of directors, and executive committee members as part of its mitigation plan for managing the financial impact COVID-19. The company has also reduced weekly hours of employees where appropriate.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,